Drugs / Livercellgram
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT01875081 | Nov 2012 → Mar 2016 | alcoholic liver cirrhosis | Pharmicell Co., Ltd. | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Livercellgram | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01875081 ↗ |
| Modality | Cell therapy | “inject 5X107 autologous bone marrow-derived mesenchymal stem cells” NCT01875081 ↗ |
| Route | Other | “Directly inject into liver through hepatic artery” NCT01875081 ↗ |